ARCHIVES

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 30 No. 06 | February 6, 2004

Download PDF Visit The Full Archive

Related Articles

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

CMS Unable to Adjust Cuts To Cancer Care

June 7, 2013

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000

Bahama Government Closes Clinic “Immediately And Permanently” After AIDs Contamination Report

July 26, 1985

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996

Data collection Completed In NCI Study of BRACA1

August 16, 1996